<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03765866</url>
  </required_header>
  <id_info>
    <org_study_id>022015-093</org_study_id>
    <nct_id>NCT03765866</nct_id>
  </id_info>
  <brief_title>Rotational Thromboelastometry Activated Transfusion In Trauma Trial</brief_title>
  <acronym>ROTATE-IT</acronym>
  <official_title>Viscoelastic Guided Goal Directed Resuscitation of Severely Injured Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Texas Southwestern Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Texas Southwestern Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized controlled trial to compare viscoelastic (VE) guided resuscitation to
      fixed-ratio resuscitation in trauma patients with hemorrhagic shock on the utilization of
      blood products, effects on coagulation and inflammatory mediators, and how these strategies
      affect post resuscitation adverse events.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is an open labeled study as the VE guided resuscitation will be based on the visible VE
      results. Aim 1 will compare the number of blood products utilized in each resuscitation
      strategy. Aim 2 will analyze the coagulation and inflammatory mediators in each resuscitation
      strategy to determine if there is a difference in the mechanism of coagulopathy. Aim 3 will
      determine if the different resuscitation strategies have an effect on post resuscitation
      adverse events.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Actual">December 17, 2018</completion_date>
  <primary_completion_date type="Actual">December 17, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in number of blood products utilized at 24 hours</measure>
    <time_frame>24 hours from time of randomization</time_frame>
    <description>Number of blood products utilized during that time frame will be recorded to determine if change in resuscitation strategies result in measurable differences</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in coagulation profile</measure>
    <time_frame>0 hours and 30 days</time_frame>
    <description>Analyze coagulation profiles in each resuscitation strategy to determine if there is a change in the mechanism of coagulopathy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in inflammatory mediators</measure>
    <time_frame>0 hours and 30 days</time_frame>
    <description>Analyze inflammatory mediators in each resuscitation strategy to determine if there is a change in the mechanism of coagulopathy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Resuscitation strategy-related adverse events</measure>
    <time_frame>30 days after admission</time_frame>
    <description>Rate of resuscitation strategies-related adverse events as a composite, including (transfusion related acute lung injury, transfusion associated circulatory overload, hyperkalemia, hypocalcemia, allergic reaction, hemolysis and transfusion transmitted infection)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">31</enrollment>
  <condition>Trauma</condition>
  <arm_group>
    <arm_group_label>Massive Transfusion Protocol Guided</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Clinicians will only transfuse patients according to standard massive transfusion protocol (MTP)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Thromboelastometry guided transfusion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Clinicians will transfuse patients according to ROTEM results.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Thromboelastometry guided transfusion</intervention_name>
    <description>Comparing resuscitation strategies with standard MTP v.s. ROTEM guided MTP</description>
    <arm_group_label>Thromboelastometry guided transfusion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Trauma patient

          2. MTP Activation

          3. Only patients ≥ 14 years old

          4. Alive at 31 mins after arrival in ED

        Exclusion Criteria:

          1. Transfer from OSH

          2. Received CPR for more than 5 mins

          3. Burned

          4. Pregnant or Prisoner

          5. Known DNR

          6. Jehovah's witness
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael W. Cripps, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>UT Southwestern Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Parkland Memorial Hospital</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75206</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Schlimp CJ, Voelckel W, Inaba K, Maegele M, Schöchl H. Impact of fibrinogen concentrate alone or with prothrombin complex concentrate (+/- fresh frozen plasma) on plasma fibrinogen level and fibrin-based clot strength (FIBTEM) in major trauma: a retrospective study. Scand J Trauma Resusc Emerg Med. 2013 Oct 8;21:74. doi: 10.1186/1757-7241-21-74.</citation>
    <PMID>24103457</PMID>
  </reference>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 23, 2016</study_first_submitted>
  <study_first_submitted_qc>December 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 5, 2018</study_first_posted>
  <last_update_submitted>May 27, 2020</last_update_submitted>
  <last_update_submitted_qc>May 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>rotational thromboelastometry</keyword>
  <keyword>viscoelastic test</keyword>
  <keyword>coagulopathy</keyword>
  <keyword>trauma</keyword>
  <keyword>hemorrhage</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

